Diets
mediterranean diet decreases hepatic steatosis NAFLD/MASLD liver fat
In plain terms: Does a Mediterranean diet reduce fatty liver (lower liver fat, ALT, stiffness)?
Part of: 🥗 mediterranean diet
Yes — pooled RCTs show the Mediterranean diet significantly lowers liver fat (MRI-PDFF), ALT and liver stiffness in MASLD/NAFLD, making it a first-line dietary recommendation.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Tsamos 2024 · Nutrients | meta-analysis | contradicts | moderate | Meta-analysis of 7 RCTs found olive oil (a core MedDiet component) did not significantly change ALT in NAFLD, tempering the surrogate-marker claim. |
| Xiong 2024 · Food Funct | meta-analysis | supports | high | Meta-analysis of RCTs found the Mediterranean diet lowered liver fat content and liver enzymes in NAFLD versus low-fat diet. |
| Jamil 2024 · BMC Public Health | meta-analysis | supports | moderate | Systematic review/meta-analysis found the Mediterranean diet improved MASLD markers in children and adolescents. |
| Reddy 2023 · Nutr Res | RCT | mixed | moderate | MEDINA RCT: MedDiet improved adiponectin without weight loss but did not significantly change most inflammatory markers versus low-fat diet. |
| Bernardino 2025 · Nutrients | observational | supports | low | Review of pediatric MASLD: MedDiet + activity + nutrition education associated with improved steatosis (weaker, non-RCT pediatric evidence). |
| Chooi 2025 · Front Nutr | RCT | supports | moderate | Secondary analysis of an RCT found MedDiet adherence improved liver fat and lipids largely independent of weight loss in women with fatty liver. |
| Yaskolka Meir 2021 · Gut | RCT | supports | high | DIRECT-PLUS RCT: green-Mediterranean diet halved NAFLD and produced the greatest intrahepatic-fat loss versus other healthy diets. |
| Stern 2026 · Eur J Nutr | meta-analysis | supports | high | Meta-analysis of MASLD RCTs (2018-2024): MedDiet reduced ALT (-2.93 IU/L), liver stiffness (-0.35 kPa) and MRI-PDFF (-1.37%) vs controls; ketogenic/omega-3 did not. |
| Tawk 2025 · JGH Open | meta-analysis | supports | moderate | Integrative review of RCTs/meta-analyses: MedDiet highlighted as particularly effective at reducing liver fat, especially combined with physical activity. |
| Del Bo 2023 · Nutrients | meta-analysis | mixed | moderate | Meta-analysis of 10 RCTs showed MedDiet reduced liver stiffness and waist circumference but effects on ALT/GGT and intrahepatic fat were modest and not all significant. |
| Zou 2025 · BMC Gastroenterol | meta-analysis | supports | moderate | Network meta-analysis of diets in MAFLD: MedDiet among the more effective patterns for improving liver function and metabolic profile. |
| Ulucay Kestane 2024 · Nutrients | RCT | supports | moderate | 8-week energy-restricted Mediterranean-diet variants improved liver enzymes and fatty liver index in obese insulin-resistant NAFLD patients. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.